• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉丁美洲和加勒比地区公共资助的国家免疫规划中的青少年疫苗接种特征:文献综述

Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature.

作者信息

Rojas Monica, Florencia Lución Maria, Becker Feijó Ricardo, Luevanos Antonio, Gutierrez Tobar Ivan Felipe, Estripeaut Dora, Schilling Andrea, Webster Jessica, Eugenia Perez Maria, Hirata Luciana, Orengo Juan Carlos, Irene Parellada Cintia

机构信息

Outcomes Research-Regional Latin America, MSD Colombia SAS, Bogotá, Colombia.

Department of Epidemiology, Hospital de Niños Dr. Ricardo Gutiérrez, Buenos Aires, Argentina.

出版信息

Hum Vaccin Immunother. 2025 Dec;21(1):2528403. doi: 10.1080/21645515.2025.2528403. Epub 2025 Jul 11.

DOI:10.1080/21645515.2025.2528403
PMID:40643044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12258168/
Abstract

This review aimed to characterize adolescent vaccination schedules in publicly funded national immunization programs in Latin America and the Caribbean. The initial review identified vaccine type, target age and gender, dose schedule, and vaccination coverage rate (VCR) across 50 countries/territories in the region. A systematic review from January 2010-October 2023 was then conducted to identify primary data collection studies reporting VCRs. Overall, 42 webpages and 23 primary studies were identified. Among 47 countries/territories with ≥1 vaccine for adolescent immunization, human papillomavirus (HPV) vaccine was included in 45, tetanus component vaccines in 43, and meningococcal vaccines in 10. Catch-up vaccination for hepatitis B in 17, and yellow fever in all 13 endemic countries/territories. VCRs were primarily available for HPV. The findings of this review underscore the need to prioritize adolescent vaccination, improve accessibility, and strengthen tracking infrastructure to ensure comprehensive protection of this age group across the region.

摘要

本综述旨在描述拉丁美洲和加勒比地区公共资助的国家免疫规划中的青少年疫苗接种计划。初步综述确定了该地区50个国家/地区的疫苗类型、目标年龄和性别、剂量计划以及疫苗接种覆盖率(VCR)。随后进行了一项2010年1月至2023年10月的系统综述,以确定报告VCR的原始数据收集研究。总体而言,共确定了42个网页和23项原始研究。在有≥1种青少年免疫疫苗的47个国家/地区中,45个国家/地区纳入了人乳头瘤病毒(HPV)疫苗,43个国家/地区纳入了破伤风成分疫苗,10个国家/地区纳入了脑膜炎球菌疫苗。17个国家/地区开展了乙型肝炎补种疫苗接种,所有13个流行国家/地区均开展了黄热病补种疫苗接种。VCR数据主要针对HPV疫苗。本综述的结果强调了需要优先考虑青少年疫苗接种、提高可及性并加强跟踪基础设施,以确保该地区这一年龄组得到全面保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e93/12258168/a7def3bb7414/KHVI_A_2528403_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e93/12258168/87f7dc33761d/KHVI_A_2528403_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e93/12258168/a7def3bb7414/KHVI_A_2528403_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e93/12258168/87f7dc33761d/KHVI_A_2528403_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e93/12258168/a7def3bb7414/KHVI_A_2528403_F0002_OC.jpg

相似文献

1
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature.拉丁美洲和加勒比地区公共资助的国家免疫规划中的青少年疫苗接种特征:文献综述
Hum Vaccin Immunother. 2025 Dec;21(1):2528403. doi: 10.1080/21645515.2025.2528403. Epub 2025 Jul 11.
2
Overcoming challenges and achieving high HPV vaccination uptake in Cameroon: lessons learned from a gender-neutral and single-dose program and community engagement.在喀麦隆克服挑战并提高人乳头瘤病毒(HPV)疫苗接种率:从性别中立单剂量计划和社区参与中学到的经验教训
BMC Public Health. 2025 May 8;25(1):1696. doi: 10.1186/s12889-025-22776-3.
3
Strategies to increase immunization coverage of tetanus vaccine among women in Sub Saharan Africa: a systematic review.提高撒哈拉以南非洲地区妇女破伤风疫苗免疫接种覆盖率的策略:一项系统综述
Pan Afr Med J. 2017 Jun 22;27(Suppl 3):25. doi: 10.11604/pamj.supp.2017.27.3.11535. eCollection 2017.
4
Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis.关于在青春期前女孩中,两剂与三剂 HPV 免疫接种方案相比免疫原性非劣效性的不确定证据:系统评价和荟萃分析。
J Infect. 2015 Jul;71(1):61-73. doi: 10.1016/j.jinf.2015.02.005. Epub 2015 Feb 21.
5
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.估算 2020-2030 年期间 112 个国家因与 COVID-19 相关的免疫接种中断对健康产生的影响:建模研究。
Lancet Glob Health. 2024 Apr;12(4):e563-e571. doi: 10.1016/S2214-109X(23)00603-4.
6
Public health impact and cost-effectiveness of implementing gender-neutral vaccination with a 9-valent HPV vaccine in Japan: a modeling study.日本实施9价人乳头瘤病毒疫苗性别中立接种的公共卫生影响及成本效益:一项建模研究
J Med Econ. 2025 Dec;28(1):974-985. doi: 10.1080/13696998.2025.2520703. Epub 2025 Jun 20.
7
Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review.影响青少年多剂量疫苗接种计划完成情况的因素:一项系统综述
BMC Public Health. 2016 Feb 19;16:172. doi: 10.1186/s12889-016-2845-z.
8
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.1980年至2023年全球、区域和国家儿童常规疫苗接种覆盖率趋势及2030年预测:2023年全球疾病负担研究的系统分析
Lancet. 2025 Jun 24. doi: 10.1016/S0140-6736(25)01037-2.
9
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
10
Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis.人乳头瘤病毒疫苗的两剂接种方案:系统评价与荟萃分析
Vaccine. 2017 May 19;35(22):2892-2901. doi: 10.1016/j.vaccine.2017.03.096. Epub 2017 Apr 25.

本文引用的文献

1
[Not Available].[无可用内容]
Salud Publica Mex. 2023 Jun 15;65:s23-s33. doi: 10.21149/14790.
2
Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review.人乳头瘤病毒疫苗接种年龄与疫苗有效性的系统评价。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2239085. doi: 10.1080/21645515.2023.2239085.
3
Importance of vaccination against human papillomavirus in a rural settlement in Terenos, Mato Grosso do Sul.农村聚居区开展人乳头瘤病毒疫苗接种的重要性:巴西马托格罗索州特雷诺斯案例
Rev Saude Publica. 2023 Apr 14;57:10. doi: 10.11606/s1518-8787.2023057004339. eCollection 2023.
4
Trends in Adolescent Human Papillomavirus Vaccination and Parental Hesitancy in the United States.青少年人乳头瘤病毒疫苗接种和美国父母犹豫的趋势。
J Infect Dis. 2023 Aug 31;228(5):615-626. doi: 10.1093/infdis/jiad055.
5
The Family Health Strategy Influence on the Human Papillomavirus Vaccine Acceptance in a Peripheral Community of the Brazilian Amazon Region.家庭健康战略对巴西亚马逊地区一个周边社区人乳头瘤病毒疫苗接种接受度的影响
Health Equity. 2022 Nov 18;6(1):852-861. doi: 10.1089/heq.2022.0009. eCollection 2022.
6
Vaccination against human papillomavirus in Brazilian schoolchildren: National Survey of School Health, 2019.巴西学童的人乳头瘤病毒疫苗接种:2019 年学校卫生国家调查。
Rev Lat Am Enfermagem. 2022 Nov 28;30(spe):e3834. doi: 10.1590/1518-8345.6296.3834. eCollection 2022.
7
Routine Vaccination Coverage - Worldwide, 2021.常规疫苗接种覆盖率-全球,2021 年。
MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1396-1400. doi: 10.15585/mmwr.mm7144a2.
8
Regional differences and temporal trend analysis of Hepatitis B in Brazil.巴西乙型肝炎的地区差异和时间趋势分析。
BMC Public Health. 2022 Oct 17;22(1):1931. doi: 10.1186/s12889-022-14296-1.
9
Knowledge, attitudes, and practices of adolescents regarding human papillomavirus.青少年对人乳头瘤病毒的认知、态度和实践。
Rev Saude Publica. 2022 Apr 1;56:12. doi: 10.11606/s1518-8787.2022056003639. eCollection 2022.
10
Vaccine hesitancy in Argentina: Validation of WHO scale for parents.阿根廷的疫苗犹豫:世界卫生组织父母量表的验证。
Vaccine. 2021 Jul 30;39(33):4611-4619. doi: 10.1016/j.vaccine.2021.06.080. Epub 2021 Jul 5.